Psychiatric symptoms in Parkinson's disease

European Archives of Psychiatry and Clinical Neuroscience

Volumn 258, Issue SUPPL. 5, 2008, Pages 55-59

  Schneider, Frank ^a   Althaus, Astrid ^a,b   Backes, Volker ^a   Dodel, Richard ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Anxiety; Deep brain stimulation; Depression; Hallucinations; Parkinson's disease; Psychosis; Quality of life

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGRANULOCYTOSIS; ANXIETY DISORDER; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE THERAPY; CONFERENCE PAPER; DELUSION; DEPRESSION; DRUG DOSE REDUCTION; ELECTROCONVULSIVE THERAPY; GENERALIZED ANXIETY DISORDER; HALLUCINATION; HUMAN; HYPERTENSIVE CRISIS; ILLUSION; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PANIC; PARKINSON DISEASE; PARKINSONISM; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; PSYCHOSOCIAL CARE; SOCIAL PHOBIA; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANXIETY; DEEP BRAIN STIMULATION; DEPRESSION; HUMANS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 55549137746     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-008-5012-4     Document Type: Conference Paper

References (41)

1. D Aarsland JP Larsen JL Cummins K Laake 1999 Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study Arch Neurol 56 595 601
2. Althaus A, Arranz Becker O, Spottke A, Dengler R, Schneider F, Kloss M, Eggert K, Oertel WH, Dillmann U, Herting B, Classen J, Dodel R (2008) Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord
3. R Brown M Jahanshahi 1995 Depression in Parkinson's disease: a psychosocial viewpoint Adv Neurol 65 61 84
4. DJ Burn 2002 Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease Mov Disord 17 445 454
5. L Castelli P Perozzo M Zibetti B Crivelli U Morabito M Lanotte F Cossa B Bergamasco L Lopiano 2006 Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits Eur Neurol 55 136 144
6. JJ Chen 2004 Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges Neurol Clin 22 S63 S90
7. G Deuschl C Schade-Brittinger P Krack J Volkmann H Schafer K Botzel C Daniels A Deutschlander U Dillmann W Eisner D Gruber W Hamel J Herzog R Hilker S Klebe M Kloss J Koy M Krause A Kupsch D Lorenz S Lorenzl HM Mehdorn JR Moringlane W Oertel MO Pinsker H Reichmann A Reuss GH Schneider A Schnitzler U Steude V Sturm L Timmermann V Tronnier T Trottenberg L Wojtecki E Wolf W Poewe J Voges 2006 A randomized trial of deep-brain stimulation for Parkinson's disease N Engl J Med 355 896 908
8. TS Ehmann RJ Beninger MJ Gawel RJ Riopelle 1990 Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects J Geriatr Psychiatry Neurol 3 3 9
9. G Fenelon CG Goetz A Karenberg 2006 Hallucinations in Parkinson disease in the prelevodopa era Neurology 66 93 98
10. G Fenelon F Mahieux R Huon M Ziegler 2000 Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors Brain 123 Pt 4 733 745
11. HH Fernandez D Aarsland G Fenelon JH Friedman L Marsh AI Troster W Poewe O Rascol C Sampaio GT Stebbins CG Goetz 2008 Scales to assess psychosis in Parkinson's disease: critique and recommendations Mov Disord 23 484 500
12. HH Fernandez ME Trieschmann MA Burke C Jacques JH Friedman 2003 Long-term outcome of quetiapine use for psychosis among Parkinsonian patients Mov Disord 18 510 514
13. H Frieling T Hillemacher M Ziegenbein B Neundorfer S Bleich 2007 Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis Eur Neuropsychopharmacol 17 165 171
14. Ghazi-Noori S, Chung TH, Deane KHO, Rickards H, Clarke CE (2007) Therapies for depression in Parkinson's disease (Review) Cochrane Database of Systematic Reviews 2003
15. FJ Jimenez-Jimenez J Tejeiro G Martinez-Junquera F Cabrera-Valdivia J Alarcon E Garcia-Albea 1994 Parkinsonism exacerbated by paroxetine Neurology 44 2406
16. L Kerenyi GA Ricaurte DJ Schretlen U McCann J Varga WB Mathews HT Ravert RF Dannals J Hilton DF Wong Z Szabo 2003 Positron emission tomography of striatal serotonin transporters in Parkinson disease Arch Neurol 60 1223 1229
17. SE Kim JY Choi YS Choe Y Choi WY Lee 2003 Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT J Nucl Med 44 870 876
18. P Krack A Batir N Van Blercom S Chabardes V Fraix C Ardouin A Koudsie PD Limousin A Benazzouz JF LeBas AL Benabid P Pollak 2003 Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease N Engl J Med 349 1925 1934
19. A Leentjens M Van den Akker J Metsemakers R Lousberg F Verhey 2003 Higher incidence of depression preceding the onset of Parkinson's disease: a register study Mov Disord 18 414 418
20. L Marsh WM McDonald J Cummings B Ravina 2006 Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group Mov Disord 21 148 158
21. L Marsh JR Williams M Rocco S Grill C Munro TM Dawson 2004 Psychiatric comorbidities in patients with Parkinson disease and psychosis Neurology 63 293 300
22. A Nuti R Ceravolo A Piccinni G Dell'Agnello G Bellini G Gambaccini C Rossi C Logi L Dell'Osso U Bonuccelli 2004 Psychiatric comorbidity in a population of Parkinson's disease patients Eur J Neurol 11 315 320
23. WH Oertel GU Hoglinger T Caraceni F Girotti T Eichhorn AE Spottke JC Krieg W Poewe 2001 Depression in Parkinson's disease. An update Adv Neurol 86 373 383
24. JS Reijnders U Ehrt WE Weber D Aarsland AF Leentjens 2008 A systematic review of prevalence studies of depression in Parkinson's disease Mov Disord 23 183 189 quiz 313
25. Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU (2008) Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 255(2):255-264
26. A Rojo M Aguilar MT Garolera E Cubo I Navas S Quintana 2003 Depression in Parkinson's disease: clinical correlates and outcome Parkinsonism Relat Disord 10 23 28
27. F Schneider U Habel J Volkmann S Regel J Kornischka V Sturm HJ Freund 2003 Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease Arch Gen Psychiatry 60 296 302
28. A Schuurman M van den Akker K Ensinck J Metsemakers J Knottnerus A Leentjens F Buntinx 2002 Increased risk of Parkinson's disease after depression: a retrospective cohort study Neurology 58 1501 1504
29. Shabnam GN, Th C, Kho D, H R, Ce C (2003) Therapies for depression in Parkinson's disease. Cochrane Database Syst Rev: CD003465
30. SE Starkstein M Merello R Jorge S Brockman D Bruce G Petracca RG Robinson 2008 A validation study of depressive syndromes in Parkinson's disease Mov Disord 23 538 546
31. MB Stein IJ Heuser JL Juncos TW Uhde 1990 Anxiety disorders in patients with Parkinson's disease Am J Psychiatry 147 217 220
32. S Takeshita K Kurisu L Trop K Arita T Akimitsu NP Verhoeff 2005 Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems Neurosurg Rev 28 179 186 discussion 187
33. A Vazquez FJ Jimenez-Jimenez P Garcia-Ruiz D Garcia-Urra 1993 "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy Acta Neurol Scand 87 14 18
34. C Veazey SO Aki KF Cook EC Lai ME Kunik 2005 Prevalence and treatment of depression in Parkinson's disease J Neuropsychiatry Clin Neurosci 17 310 323
35. S von Campenhausen B Bornschein R Wick K Botzel C Sampaio W Poewe W Oertel U Siebert K Berger R Dodel 2005 Prevalence and incidence of Parkinson's disease in Europe Eur Neuropsychopharmacol 4 473 490
36. K Walsh G Bennett 2001 Parkinson's disease and anxiety Postgrad Med J 77 89 93
37. D Weintraub HI Hurtig 2007 Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies Am J Psychiatry 164 1491 1498
38. D Weintraub KH Morales PJ Moberg WB Bilker C Balderston JE Duda IR Katz MB Stern 2005 Antidepressant studies in Parkinson's disease: a review and meta-analysis Mov Disord 20 1161 1169
39. MG Weisskopf H Chen MA Schwarzschild I Kawachi A Ascherio 2003 Prospective study of phobic anxiety and risk of Parkinson's disease Mov Disord 18 646 651
40. DP Wint MS Okun HH Fernandez 2004 Psychosis in Parkinson's disease J Geriatr Psychiatry Neurol 17 127 136
41. EC Wolters 1999 Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment Neurology 52 S10 S13